Search results
Results from the WOW.Com Content Network
Strides Pharma Science Limited is an Indian pharmaceutical company, headquartered at Bangalore. The company manufactures pharmaceutical products, over-the-counter drugs and nutraceuticals. Products include softgel capsules, hard-gel capsules, tablets and dry and wet injectables. The company has 15 manufacturing sites in six countries and ...
Construction and civil engineering : WSP Global : CCCC, China Railway Group, China Railway Construction : ACS Group, Acciona, FCC, Grupo Ferrovial : Orascom Construction Industries
The New York City Economic Development Corporation's Early Stage Life Sciences Funding Initiative and venture capital partners, including Celgene, General Electric Ventures, and Eli Lilly, committed a minimum of US$100 million to help launch 15 to 20 ventures in life sciences and biotechnology in 2014, [6] and in January 2018, the City of New ...
By Brad Sorensen, CFA NASDAQ:SPRC SciSparc Ltd. (NASDAQ:SPRC) (“SciSparc”) is a specialty clinical-stage pharmaceutical company focusing on creating and enhancing a portfolio of technologies ...
It was sold to Strides Arcolab through a share purchase agreement with Haw Par Healthcare Limited, Singapore in September 2006 for approximately SGD$19.7 million. It is currently a part of Strides Arcolab which is listed on both the Indian stock exchanges Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE).
This page was last edited on 11 February 2019, at 01:46 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may apply.
The University of Toronto was the only school in Ontario to offer a pharmacy education until the opening of the University of Waterloo School of Pharmacy in 2008. In 1877, the Faculty moved into the University of Toronto campus, and new levels of pharmaceutical education was offered as a PhD degree at the University of Toronto was being ...
Patheon was founded in Fort Erie, Ontario in 1974 as Custom Pharmaceuticals Ltd. In 1990, it began to expand to US markets. Custom Pharmaceuticals changed its name to Patheon in 1993 and was first publicly traded that year on the Toronto Stock Exchange. [1] In 2004, Patheon acquired MOVA, a drug manufacturer based in Puerto Rico, US.